Recruiting studies: Cancer Of The Pancreas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.
NA · 1 location(s) · Gansu Wuwei Tumor Hospital · NCT06840067 Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Phase 3 · 31 location(s) · Immuneering Corporation · NCT07562152 Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06800469 A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
Phase 1 · 5 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06403735 Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Phase 2 · 10 location(s) · EXACT Therapeutics AS · NCT06850623 Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Tr
Phase 3 · 4 location(s) · M.D. Anderson Cancer Center · NCT06593431 Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Phase N/A · 10 location(s) · Peking Union Medical College Hospital · NCT06375473 Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Phase 1 · 17 location(s) · SystImmune Inc. · NCT07021066 Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver
NA · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06307080 The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cel
Phase N/A · 4 location(s) · Javier Toledo · NCT06717295 Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver
Phase 2 · 1 location(s) · Azienda Ospedaliera di Padova · NCT06690528 A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07283705 Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · 117 location(s) · Exelixis · NCT06943755 Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
Phase 1/Phase 2 · 1 location(s) · Chinese PLA General Hospital · NCT05218889 Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Phase N/A · 1 location(s) · Herlev Hospital · NCT07272187 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Phase 1 · 10 location(s) · Dren Bio · NCT06999187 Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 1/Phase 2 · 21 location(s) · Revolution Medicines, Inc. · NCT05379985 Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Phase N/A · 1 location(s) · Changhai Hospital · NCT04743479 Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT02393703 Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Phase 1/Phase 2 · 1 location(s) · University Hospital, Lille · NCT05116072 Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07627711 A Study of GC203 TIL in PDCA (RJ)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06828328 Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
NA · 5 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05850130 Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
NA · 1 location(s) · Fox Chase Cancer Center · NCT06984562 MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07619391 Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Phase N/A · 2 location(s) · Zhejiang University · NCT07359586 Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
Phase 2 · 1 location(s) · National Cancer Centre, Singapore · NCT05929885 Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
Phase 1/Phase 2 · 1 location(s) · Vector Vitale LLC · NCT06506643 The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
NA · 1 location(s) · HistoSonics, Inc. · NCT06282809 Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With C
Phase 2/Phase 3 · 2 location(s) · GE Healthcare · NCT07219238

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →